Peripheral cases
Recanalization of CTO, Calcified Right Distal Superficial Femoral Artery – June 2014

| | | |

Views 393

59 year old male patient with complaints of life style limiting claudication symptoms in right leg at rest (Rutherford Grade II category 4) on medication (cilostazol) and exercise program on presentation. Past Medical History: Hypertension, Dyslipidemia, DM type II, HIV. Medications: Medications: Aspirin, cilostazol, Metoprolol, Amlodipine, Atorvastatin. Social History: Non Smoker, no alcohol or IVDA.

Patient now planned for Recanalizaton of CTO, calcified right distal superficial femoral artery.



Leave a Reply

Your email address will not be published. Required fields are marked *

Popliteal Artery CTO Intervention for Severe Intermittent Claudication & Rest Pain – Sept 2019
Views 270

The patient is a 79 Male with hypertension, non-insulin dependent diabetes, dyslipidemia and coronary artery disease (status post CABG), who presents with lower extremity claudication (Rutherford 4) that has progressed to pain at rest. He has failed exercised and medical therapy. Non-Invasive imaging done shows occluded popliteal artery. Now referred for angiography and possible intervention […]

Calcified SFA CTO Lesion w/ Prior Failed Intervention – August 2019
Tags: | | |
Views 423

59-year-old male with hypertension, insulin-dependent diabetes, smoking history, presenting with worsening lifestyle limiting claudication, now progressing to pain at rest. US done shows bilateral SFA CTO disease.

Peripheral intervention live webcast – July 2019
Tags: |
Views 263

71-year-old female Patient with hypertension, hyperlipidemia and active smoking. She presents with left lower extremity claudication (Buttock, thigh and calf) Rutherford class 3. US-Doppler revealed blunted waveform over the left iliac artery. CT-angiogram revealed total occlusion of the left common iliac artery with reconstitution in the external iliac artery.

Complex AT CTO Intervention – June 2019
Views 269

74 year old female patient with HTN, HLD, DM2 (Insulin therapy), Hypothyroidism.